Sickle Cell Disease
Sickle cell disease, also known as sickle cell anemia, is an inherited disorder that affects an estimated 100,000 Americans. While sickle cell disease can affect anyone, it is most common in people whose ancestors came from Africa, the Middle East, India and Spanish-speaking regions in the Western Hemisphere (Central and South America except Brazil, Spain and the Caribbean). Currently, the only potentially curative treatment available for sickle cell disease is blood and marrow transplant.
The University of Kansas Cancer Center is uniquely qualified to support patients with sickle cell disease through transplant. As 1 of fewer than 60 National Cancer Institute-designated comprehensive cancer centers in the nation, we offer unparalleled expertise in using blood and marrow transplant to treat both cancerous and noncancerous blood disorders, including sickle cell disease. In our program’s history, our team has performed more than 4,000 transplant procedures, including the first in Kansas to treat adult sickle cell disease.
A future without limits
Start your path today.
Your journey to health starts here. Call 913-588-1227 or request an appointment at The University of Kansas Cancer Center.